It was found in NAFLD patients that after activation of the NLRP3 inflammasome, hepatocytes pyroptosis occurs and releases inflammasome protein, which further drives inflammation and fibrosis reduce liver injury (Gaul et al., 2021). The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatotic liver disease.